Not applicableUnknownNCT00306280What this trial is testingFeasibility Study of Phototherapy System to Treat H PyloriWho this might be right forHelicobacter Pylori LumeRx 60
Testing effectiveness (Phase 2)Study completedNCT01471470What this trial is testingEfficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric CancerWho this might be right forAdvanced Gastric Cancer Asan Medical Center 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT02931890What this trial is testingMulticentric Randomised Trial for Resectable Gastric CancerWho this might be right forGastric Cancer The Netherlands Cancer Institute 207
Early research (Phase 1)WithdrawnNCT02831179What this trial is testingVeliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWho this might be right forFunctional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03686488What this trial is testingTAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaGastric Cancer H. Lee Moffitt Cancer Center and Research Institute 23
Not applicableNot Yet RecruitingNCT07645742What this trial is testingPilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWho this might be right forCancer (Advanced Stage) West Virginia University 90
Testing effectiveness (Phase 2)UnknownNCT05541146What this trial is testingIntraperitoneal Chemotherapy in Gastric Cancer With Peritoneal CarcinomatosisWho this might be right forGastric CancerPeritoneal Carcinomatosis Instituto do Cancer do Estado de São Paulo 30
Large-scale testing (Phase 3)WithdrawnNCT01860742What this trial is testingRandomized Phase III of PRRT Versus InterferonWho this might be right forGastro-intestinal Neuroendocrine Tumors Jules Bordet Institute
Testing effectiveness (Phase 2)Ended earlyNCT00595985What this trial is testingSorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric CancerWho this might be right forGastric Cancer Fudan University 5
Testing effectiveness (Phase 2)UnknownNCT03144843What this trial is testingApatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.Who this might be right forGastric Cancer Sun Yat-sen University 110
Large-scale testing (Phase 3)Looking for participantsNCT07103668What this trial is testingA Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer PatientsWho this might be right forGastric Adenocarcinoma Suzhou Immunofoco Biotechnology Co., Ltd 150
Testing effectiveness (Phase 2)UnknownNCT05342389What this trial is testingCamrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric CancerWho this might be right forMetastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma Sixth Affiliated Hospital, Sun Yat-sen University 68
Early research (Phase 1)Study completedNCT04564040What this trial is testingA Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for RabeprazoleWho this might be right forMantle Cell LymphomaCOVID-19 AstraZeneca 20
Testing effectiveness (Phase 2)Looking for participantsNCT07474324What this trial is testingDisitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical TrialWho this might be right forGC/GEJC The First Affiliated Hospital with Nanjing Medical University 124
Large-scale testing (Phase 3)Study completedNCT00486954What this trial is testingLapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric CancerWho this might be right forNeoplasms, Gastrointestinal Tract GlaxoSmithKline 273
Testing effectiveness (Phase 2)UnknownNCT05019794What this trial is testingInfigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR AlterationsWho this might be right forGastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor LianBio LLC 80
Large-scale testing (Phase 3)Study completedNCT00149201What this trial is testing5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal MetastasisWho this might be right forGastric CancerNeoplasm Metastasis Japan Clinical Oncology Group 160
Large-scale testing (Phase 3)Study completedNCT01839773What this trial is testingPhase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric CancerWho this might be right forStage IV Gastric Cancer Daehwa Pharmaceutical Co., Ltd. 238
Testing effectiveness (Phase 2)Study completedNCT04770623What this trial is testingDocetaxel and Irinotecan in Gastric CancerWho this might be right forStomach CancerGastric CancerChemotherapy Effect Menoufia University 32
Early research (Phase 1)Looking for participantsNCT06873659What this trial is testingSON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorGastric CancerLiver Cancer Qurgen Inc. 96